Genentech's Venetoclax Drug For Lymphocytic Leukemia Medicine & Technology Aug 13, 2015 The pharmaceutical company Genentech announced that the Phase II study for Venetoclax has meet its primary endpoint.
Space Weather Alert: NOAA Warns of a Solar Radiation Storm With 60% Chance of Hitting the Earth This Week
SPACE Helium Leak Delays Boeing’s Astronaut Launch Attempt for the Second Time; Crew Debut Set on May 21 After Spacecraft Repair
SPACE Bizarre Planet 'WASP-193b' Found To Have the Density of Cotton Candy Despite Its Enormous Size, Making It Second-Least Dense Exoplanet Ever Discovered